Literature DB >> 1319877

Absence of drug interaction between temafloxacin and low dose heparin.

T Mant1, P Morrison, E Millar.   

Abstract

An open 5-day study was conducted in 12 healthy male volunteers to determine the potential for drug interaction between low dose standard heparin and temafloxacin, a new fluorinated quinolone antibiotic. Heparin 5000IU was administered subcutaneously on the morning of the first and last study days and temafloxacin 600mg was administered twice daily for 4 days. The mean change in activated factor X (antifactor Xa) concentration relative to baseline 2h after coadministration was similar to that after heparin alone. Likewise, changes in activated partial prothrombin time, prothrombin time and thrombin time were similar after either heparin alone or concomitant temafloxacin administration, indicating the absence of interaction between temafloxacin and low dose standard heparin in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319877     DOI: 10.2165/00003088-199200221-00016

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  7 in total

Review 1.  Heparin.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

2.  Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.

Authors:  V Bode; D Welzel; G Franz; U Polensky
Journal:  Arch Intern Med       Date:  1990-10

3.  Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality.

Authors:  R C Becker; J M Corrao; E G Bovill; J M Gore; S P Baker; M L Miller; F V Lucas; J A Alpert
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

4.  The adverse effects of fluoroquinolones.

Authors:  C R Smith
Journal:  J Antimicrob Chemother       Date:  1987-06       Impact factor: 5.790

Review 5.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 6.  Overview of drug interactions with the quinolones.

Authors:  P G Davey
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

Review 7.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.